New cancer clinical trial: Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -

Published on: January 28, 2019 at 12:00PM
Condition:   Breast Cancer
Interventions:   Drug: Pre treatment Recurrence Score:18-25 Letrozole + Palbociclib;   Drug: Pre treatment Recurrence Score:26-100 Letrozole + Palbociclib
Sponsors:   MedSIR;   Pfizer
Not yet recruiting
http://bit.ly/2RldYLy